剪接体
乙酰化
奥拉帕尼
癌症研究
生物
肝细胞癌
DNA损伤
RNA剪接
DNA修复
外显子
化学
计算生物学
细胞生物学
聚ADP核糖聚合酶
遗传学
DNA
聚合酶
基因
核糖核酸
作者
Linmao Sun,Yufeng Liu,Xinyu Guo,Tianming Cui,Chenghui Wu,Jie Tao,Cheng Cheng,Qi Chu,Changyong Ji,Xianying Li,Hongrui Guo,Shuhang Liang,Huanran Zhou,Shuo Zhou,Kun Ma,Ning Zhang,Jiabei Wang,Yao Liu,Lianxin Liu
标识
DOI:10.1038/s41467-024-49573-7
摘要
Despite the importance of spliceosome core components in cellular processes, their roles in cancer development, including hepatocellular carcinoma (HCC), remain poorly understood. In this study, we uncover a critical role for SmD2, a core component of the spliceosome machinery, in modulating DNA damage in HCC through its impact on BRCA1/FANC cassette exons and expression. Our findings reveal that SmD2 depletion sensitizes HCC cells to PARP inhibitors, expanding the potential therapeutic targets. We also demonstrate that SmD2 acetylation by p300 leads to its degradation, while HDAC2-mediated deacetylation stabilizes SmD2. Importantly, we show that the combination of Romidepsin and Olaparib exhibits significant therapeutic potential in multiple HCC models, highlighting the promise of targeting SmD2 acetylation and HDAC2 inhibition alongside PARP inhibitors for HCC treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI